DM
NGNE icon

Deerfield Management’s Neurogene NGNE Stock Holding History

Deerfield Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-446,880
Closed -$5.23M – 151
2025
Q1 		$5.23M Sell
446,880
-1,265
-0.3% -$22K 0.1% 79
2024
Q4 		$10.2M Buy
+448,145
New +$16.7M 0.19% 66
2014
Q2 		– Sell
-3,119
Closed -$794K – 141
2014
Q1 		$794K Buy
+3,119
New +$802K 0.03% 121

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Deerfield Management's NGNE Position: Q2 2025 in Review

Deerfield Management sold out of Neurogene (NGNE) in Q2 2025, closing a stake of 446,880 shares — an estimated $5.23M sold.

Deerfield Management first reported a position in NGNE in Q1 2014 and held it in 3 quarters. The position peaked at $10.2M in Q4 2024. 82 funds tracked by Wall St. Rank hold NGNE as of Q2 2025.

  • Deerfield Management reported no remaining Neurogene position as of Q2 2025 after selling out during the quarter.
  • Deerfield Management sold 446,880 Neurogene shares in Q2 2025, an estimated $5.23M.
  • Deerfield Management first reported a position in Neurogene in Q1 2014 and held it in 3 quarters.
  • Deerfield Management's Neurogene position peaked at $10.2M in Q4 2024.
  • 82 funds tracked by Wall St. Rank held Neurogene as of Q2 2025.

Based on Deerfield Management's 13F filing for Q2 2025, filed 14 Aug 2025.